Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127330741 | 12733074 | 1 | I | 20020317 | 20020320 | 20160912 | 20160912 | EXP | US-OTSUKA-KJ20021800 | OTSUKA | 58.94 | YR | M | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127330741 | 12733074 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | 2 DF, BID | 582 | DF | Y | 0 | 2 | DF | TABLET | BID | |||
127330741 | 12733074 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | 1 DF, BID | 582 | DF | Y | 0 | 1 | DF | TABLET | BID | |||
127330741 | 12733074 | 3 | C | ZESTRIL | LISINOPRIL | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
127330741 | 12733074 | 4 | C | GLYNASE | GLYBURIDE | 1 | Oral | 6 MG, QD | 0 | 6 | MG | TABLET | QD | ||||||
127330741 | 12733074 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
127330741 | 12733074 | 6 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 1500 MG, QD | 0 | 1500 | MG | TABLET | QD | ||||||
127330741 | 12733074 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
127330741 | 12733074 | 8 | C | CARDIOTEC | TECHNETIUM TC-99M TEBOROXIME | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
127330741 | 12733074 | 9 | C | AVANDIA | ROSIGLITAZONE MALEATE | 1 | Oral | 4 MG, QD | 0 | 4 | MG | TABLET | QD | ||||||
127330741 | 12733074 | 10 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 240 MG, QD | 0 | 240 | MG | TABLET | QD | ||||||
127330741 | 12733074 | 11 | C | ROBINUL | GLYCOPYRROLATE | 1 | Oral | 2 MG, QD | 0 | 2 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127330741 | 12733074 | 1 | Intermittent claudication |
127330741 | 12733074 | 3 | Product used for unknown indication |
127330741 | 12733074 | 4 | Product used for unknown indication |
127330741 | 12733074 | 5 | Product used for unknown indication |
127330741 | 12733074 | 7 | Product used for unknown indication |
127330741 | 12733074 | 8 | Product used for unknown indication |
127330741 | 12733074 | 9 | Product used for unknown indication |
127330741 | 12733074 | 10 | Product used for unknown indication |
127330741 | 12733074 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127330741 | 12733074 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127330741 | 12733074 | Anaemia | |
127330741 | 12733074 | Dyspnoea | |
127330741 | 12733074 | Epididymitis | |
127330741 | 12733074 | Gastritis | |
127330741 | 12733074 | Oesophagitis | |
127330741 | 12733074 | Peptic ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127330741 | 12733074 | 1 | 20011211 | 20020317 | 0 | |
127330741 | 12733074 | 2 | 20011211 | 20020317 | 0 | |
127330741 | 12733074 | 3 | 20010914 | 0 | ||
127330741 | 12733074 | 4 | 2000 | 0 | ||
127330741 | 12733074 | 5 | 1998 | 0 | ||
127330741 | 12733074 | 6 | 1995 | 0 | ||
127330741 | 12733074 | 7 | 2000 | 0 | ||
127330741 | 12733074 | 8 | 20010914 | 0 | ||
127330741 | 12733074 | 9 | 20010914 | 0 | ||
127330741 | 12733074 | 10 | 1998 | 0 | ||
127330741 | 12733074 | 11 | 20011112 | 0 |